Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Xiaowen Peng, Auburndale US

Xiaowen Peng, Auburndale, MA US

Patent application numberDescriptionPublished
20090274686NUCLEOSIDE PHOSPHONATE DERIVATIVES - The present invention discloses compounds of formula (I) or (II), or pharmaceutically acceptable salts, esters, or prodrugs thereof:11-05-2009
201000748894'-ALLENE-SUBSTITUTED NUCLEOSIDE DERIVATIVES - The present invention discloses compounds of formula (I), or its β-L enantiomer, or a pharmaceutically acceptable salt, ester, stereoisomer, tautomer, solvate, prodrug, or combination thereof:03-25-2010
20100135960ANTIVIRAL ACYLSULFONAMIDE DERIVATIVES - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:06-03-2010
20100221214LINKED DIBENZIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:09-02-2010
20100221215LINKED DIBENZIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:09-02-2010
20100226882LINKED DIIMIDAZOLE ANTIVIRALS - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:09-09-2010
20100226883LINKED DIIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:09-09-2010
20100233122NOVEL BENZIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:09-16-2010
20100260715HEPATITIS C VIRUS INHIBITORS - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:10-14-2010
20100266543LINKED DIBENZIMIDAZOLE ANTIVIRALS - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:10-21-2010
20100316607HEPATITIS C VIRUS INHIBITORS - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:12-16-2010
20110008288HEPATITIS C VIRUS INHIBITORS - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:01-13-2011

Patent applications by Xiaowen Peng, Auburndale, MA US